Zevia Announces Third Quarter 2022 Results

Rhea-AI Summary

Zevia PBC (NYSE: ZVIA) reported a strong third quarter for 2022, with net sales rising 13.6% year over year to $44.2 million. The gross profit margin improved to 43.3%, reflecting a 90 basis point sequential increase. The company achieved a $9.2 million net loss, better than the previous year’s $49.8 million loss. Adjusted EBITDA loss was reduced to $2.1 million, marking a 67.7% sequential improvement. Despite challenges in inventory management, Zevia updated its full-year guidance to forecast net sales between $158 million and $160 million, projecting a 14.2% to 15.7% increase from 2021.

Positive

• Net sales increased 13.6% year over year to $44.2 million.
• Gross profit margin improved to 43.3%, up 90 basis points sequentially.
• Net loss significantly reduced to $9.2 million from $49.8 million in Q3 2021.
• Adjusted EBITDA loss narrowed to $2.1 million, a $1.5 million improvement year over year.
• Updated guidance projects full-year net sales of $158 million to $160 million, a 14.2% to 15.7% increase versus 2021.

Negative

• Net loss of $9.2 million still indicates ongoing financial challenges.
• Gross profit margin decreased from 45.6% year-over-year due to inflationary pressures.

Gross Margin of 43.3%⁽¹⁾, up 90 basis points sequentially

37.8% sequential improvement in Net Loss and 67.7% sequential improvement in Adjusted EBITDA⁽²⁾

Resetting 2022 Net Sales outlook

LOS ANGELES--(BUSINESS WIRE)-- Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the company disrupting the liquid refreshment beverage industry with great tasting, zero sugar beverages made with simple, plant-based ingredients, today reported results for the third quarter ended September 30, 2022.

Third Quarter 2022 Highlights

• Net sales increased 13.6% year over year to $44.2 million
• Unit volume increased 2.3% year over year to 3.6 million equivalized cases
• Gross profit margin of 43.3%⁽¹⁾
• Net loss was $9.2 million, including $6.8 million of non-cash equity-based compensation expense
• Loss per share was $0.17 per diluted share to Zevia’s Class A Common stockholders
• Adjusted EBITDA loss was $2.1 million⁽²⁾, a $1.5 million improvement year over year

“This quarter Zevia delivered strong sequential improvement in key metrics, including 90 basis points of gross margin expansion, a 67.7% reduction in our Adjusted EBITDA loss, and a 37.8% reduction in our net losses, demonstrating meaningful progress on our path to profitability and in improving cash flow. Our top line has been impacted by new pressures of inventory management at select customers, which we expect to be transitory but to continue through 2022,” said Amy Taylor, President and Chief Executive Officer of Zevia.

Taylor continued “We have tempered our 2022 net sales outlook considering these customer dynamics and the broader macroeconomic environment, and as we reset our operating model for sustainable profitable growth. Our brand and consumer metrics remain strong, leading category trends in dollars and volume as reflected in scan data across all channels, which underscores Zevia’s brand strength and long-term growth trajectory.”

(1) Gross margin presented is after reclassification of repackaging and handling costs from cost of goods sold to selling and marketing expenses during the period. The Company believes this classification change better portrays the financial impacts of the fulfillment activities conducted by the Company. The Company made this change in classification during the third quarter of 2022 as a result of an increasing trend in the occurrence of such fulfillment costs in the business. See the supplementary schedules in this press release for further information around the impact of the reclassification.
(2) Adjusted EBITDA is a non-GAAP financial measure. See the supplementary schedules in this press release for a discussion of how we define and calculate this measure and a reconciliation thereof to the most directly comparable GAAP measure.

Third Quarter Results

Net sales increased 13.6% to $44.2 million in the third quarter of 2022 compared to $39.0 million in the third quarter of 2021. Growth in net sales was primarily driven by higher price realizations and volumes that increased 2.3% versus the year-earlier period.

Gross profit improved to $19.2 million for the third quarter of 2022, a 7.9% increase compared to $17.8 million in the third quarter of 2021, reflecting net sales growth partially offset by higher cost of goods sold. Gross profit margin of 43.3% was up 90 basis points on a sequential basis and compared to 45.6% in the year earlier period. The year-over-year decline in gross profit margin was primarily due to the impact of inflationary pressures partially offset by price increases.

Selling and marketing expense was $12.9 million, or 29.2%, of net sales in the third quarter of 2022 compared to $13.6 million, or 34.9%, of net sales in the third quarter of 2021. The decrease was primarily due to lower freight and warehousing costs and a reduction of non-working marketing expenses.

General and administrative expense was $8.3 million, or 18.8%, of net sales in the third quarter of 2022 compared to $7.7 million, or 19.8%, of net sales in the third quarter of 2021. The increase was due to increased headcount and personnel to support growth, partially offset by a $0.5 million decrease in public company costs due to expense optimization initiatives.

Equity-based compensation, a non-cash expense, was $6.8 million in the third quarter of 2022, of which $3.8 million was attributable to restricted stock unit awards which were accelerated upon retirement of a legacy senior management employee.

Net loss for the third quarter of 2022 was $9.2 million, compared to net loss of $49.8 million in the third quarter of 2021 and net loss of $14.8 million in the second quarter of 2022.

Loss per share for the third quarter of 2022 was $0.17 per diluted share to Zevia’s Class A Common stockholders, compared to loss per share of $0.75 in the third quarter of 2021.

Adjusted EBITDA loss was $2.1 million in the third quarter of 2022, compared to an Adjusted EBITDA loss of $3.5 million in the third quarter of 2021 and an Adjusted EBITDA loss of $6.4 million in the second quarter of 2022. Adjusted EBITDA is a non-GAAP financial measure. See the supplementary schedules in this press release for a discussion of how we define and calculate this measure and a reconciliation thereof to the most directly comparable GAAP measure.

Balance Sheet and Cash Flows

As of September 30, 2022, the Company had $49.2 million in cash and cash equivalents and short-term investments and no outstanding debt. During the first nine months of fiscal 2022, cash used in operating activities was $19.3 million compared to $13.1 million of cash used in the first nine months of 2021. During the three months ended September 30, 2022, cash provided by operating activities was $0.2 million compared to cash used in operating activities of $8.2 million and $11.4 million in the three months ended June 30, 2022, and March 31, 2022, respectively, representing sequential improvement. The Company spent $2.2 million on capital expenditures during the first nine months of fiscal 2022 to support its growth initiatives compared to capital expenditures of $2.3 million during the first nine months of 2021.

2022 Guidance

The Company is updating its guidance for the full year of 2022 to reflect recent results, management's outlook, and the current macroeconomic environment. Net sales are expected to be in the range of $158 million to $160 million, an increase of 14.2% to 15.7% versus 2021. For the fourth quarter of 2022, net sales are expected to be in the range of $30 million to $32 million.

Webcast

The Company will host a conference call today at 8:30 a.m. Eastern Time to discuss this earnings release. Investors and other interested parties may listen to the webcast of the conference call by logging on via the Investor Relations section of Zevia’s website at https://investors.zevia.com/ or directly here. A replay of the webcast will be available for approximately thirty (30) days following the call.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as “believe,” “anticipate,” “expect,” “estimate,” “intend,” “project,” “plan,” “seek,” “pursue,” "will", or words or phrases with similar meaning. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements contained in this press release relate to, among other things, statements regarding anticipated growth, strategic direction, operating environment, distribution, velocity, pricing and costs. Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, the ability to develop and maintain our brand, our ability to successfully execute on our cost reduction initiatives, change in consumer preferences, pricing factors, the impact of inflation on our sales growth and cost structure such as increased commodity, packaging, transportation and freight, warehouse, labor and other input costs and other economic, competitive and governmental factors outside of our control, such as the impact of the effects of the COVID-19 pandemic and adverse global macroeconomic conditions and geopolitical events or conflicts, that may cause our business, strategy or actual results to differ materially from the forward-looking statements. We do not intend and undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable law. Investors are referred to our filings with the U.S. Securities and Exchange Commission for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement.

About Zevia

Zevia PBC, a Delaware public benefit corporation designated as a “Certified B Corporation,” is focused on addressing the global health challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia^® beverages are made with a handful of simple, plant-based ingredients, contain no artificial sweeteners, and are Non-GMO Project verified, gluten-free, Kosher, vegan and zero sodium. As of the third quarter of 2022, Zevia is distributed in more than 31,000 retail locations in the U.S. and Canada through a diverse network of major retailers in the food, drug, mass, natural and ecommerce channels.

(ZEVIA-F)

ZEVIA PBC CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) (in thousands, except share and per share amounts)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2022				2021				2022				2021
Net sales		$	44,239			$	38,956			$	127,815			$	104,002
Cost of goods sold			25,071				21,189	(1)			73,445	(2)			54,858	(1)
Gross profit			19,168				17,767	(1)			54,370	(2)			49,144	(1)
Operating expenses:
Selling and marketing			12,916				13,597	(1)			42,845	(2)			33,237	(1)
General and administrative			8,310				7,698				28,257				19,352
Equity-based compensation			6,837				45,731				23,781				45,804
Depreciation and amortization			326				239				1,005				713
Total operating expenses			28,389				67,265				95,888				99,106
Loss from operations			(9,221	)			(49,498	)			(41,518	)			(49,962	)
Other (expense) income, net			26				(213	)			64				(251	)
Loss before income taxes			(9,195	)			(49,711	)			(41,454	)			(50,213	)
Provision for income taxes			(1	)			(50	)			(23	)			(50	)
Net loss and comprehensive loss			(9,196	)			(49,761	)			(41,477	)			(50,263	)
Net loss attributable to Zevia LLC prior to the Reorganization Transactions			—				1,411				—				1,913
Loss attributable to noncontrolling interest			1,712				22,527				12,005				22,527
Net loss attributable to Zevia PBC		$	(7,484	)		$	(25,823	)		$	(29,472	)		$	(25,823	)
Net loss per share attributable to common stockholders
Basic		$	(0.17	)		$	(0.75	)(3)		$	(0.73	)		$	(0.75	)(3)
Diluted		$	(0.17	)		$	(0.75	)(3)		$	(0.73	)		$	(0.75	)(3)
Weighted average common shares outstanding
Basic			44,072,985				34,440,982				40,393,978				34,440,982
Diluted			44,072,985				34,440,982				40,393,978				34,440,982

^{(1) Included in the accompanying results for the three months and nine months ended September 30, 2021, are $0.8 million and $1.7 million of expenses, respectively, previously recorded as cost of goods sold that the Company has reclassified to selling and marketing expenses to conform to the current presentation.
(2) Included in the accompanying results for the nine months ended September 30, 2022, are $3.2 million of expenses previously recorded as cost of goods sold during the six months ended June 30, 2022 that the Company has reclassified to selling and marketing expenses to conform to the current presentation.
(3) Represents earnings per share of Class A common stock and weighted-average shares of Class A common stock outstanding for the period from July 22,2021 through September 30, 2021, the period following the Reorganization Transactions and IPO.}

ZEVIA PBC CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (in thousands)
		September 30, 2022				December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents		$	49,236			$	43,110
Short-term investments			—				30,000
Accounts receivable, net			13,538				9,047
Inventories			37,283				31,501
Prepaid expenses and other current assets			3,356				3,421
Total current assets			103,413				117,079
Property and equipment, net			4,933				3,664
Right-of-use assets under operating leases, net			878				211
Intangible assets, net			3,588				3,738
Other non-current assets			558				301
Total assets		$	113,370			$	124,993
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable		$	19,685			$	13,492
Accrued expenses and other current liabilities			7,950				6,705
Current portion of operating lease liabilities			698				236
Total current liabilities			28,333				20,433
Operating lease liabilities, net of current portion			186				1
Total liabilities			28,519				20,434
Stockholders' equity
Class A common stock			45				34
Class B common stock			24				30
Additional paid-in capital			189,426				174,404
Accumulated deficit			(75,458	)			(45,986	)
Total Zevia PBC stockholder's equity			114,037				128,482
Noncontrolling interests			(29,186	)			(23,923	)
Total equity			84,851				104,559
Total liabilities and equity		$	113,370			$	124,993

ZEVIA PBC CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) (in thousands)
		Nine Months Ended September 30,
		2022				2021
Operating activities:
Net loss		$	(41,477	)		$	(50,263	)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash lease expense			483				417
Depreciation and amortization			1,005				713
Loss on sale of equipment			3				9
Amortization of debt issuance cost			45				94
Equity-based compensation			23,781				45,804
Changes in operating assets and liabilities:
Accounts receivable, net			(4,491	)			(7,563	)
Inventories			(5,782	)			(4,127	)
Prepaid expenses and other assets			97				(3,637	)
Accounts payable			6,248				4,010
Accrued expenses and other current liabilities			1,245				1,910
Operating lease liabilities			(503	)			(461	)
Net cash used in operating activities			(19,346	)			(13,094	)
Investing activities:
Proceeds from maturities of securities			30,000				—
Purchases of property and equipment			(2,182	)			(2,308	)
Net cash provided by (used in) investing activities			27,818				(2,308	)
Financing activities:
Proceeds from revolving line of credit			—				74,721
Repayment of revolving line of credit			—				(74,721	)
Payment of debt issuance costs			(334	)			—
Minimum tax withholding paid on behalf of employees for net share settlement			(2,130	)			—
Proceeds from exercise of stock options			118				—
Proceeds from exercise of common units			—				10
Exercise of stock options							(115	)
Repurchase of Zevia LLC units			—				(17	)
Distribution to unitholders for tax payments			—				(2,669	)
Proceeds from issuance of Class A common stock sold in IPO, net of underwriting discounts and commissions			—				139,689
Use of proceeds from issuance of Class A common stock to purchase Zevia LLC Units			—				(49,609	)
Cancellation of options in IPO			—				2
Cancellation of options			—				(4	)
Payment of IPO costs			—				(8,101	)
Net cash (used in) provided by financing activities			(2,346	)			79,186
Net change from operating, investing, and financing activities			6,126				63,784
Cash and cash equivalents at beginning of period			43,110				14,936
Cash and cash equivalents at end of period		$	49,236			$	78,720

Use of Non-GAAP Financial Information

We use Adjusted EBITDA, a financial measure that is not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). The Company’s management believes that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes.

We calculate Adjusted EBITDA as net income (loss) adjusted to exclude: (1) other income (expense), net, which includes interest (income) expense, foreign currency (gains) losses, and (gains) losses on disposal of fixed assets, (2) provision (benefit) for income taxes, (3) depreciation and amortization, and (4) equity-based compensation. Adjusted EBITDA may in the future also be adjusted for amounts impacting net income related to the Tax Receivable Agreement liability and other infrequent and unusual transactions.

Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of equity-based compensation expense, including the potential dilutive impact thereof, and (4) it does not reflect other non-operating expenses, including interest (income) expense, foreign currency (gains) losses and (gains) losses on disposal of fixed assets. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net loss or income and other results stated in accordance with GAAP.

The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted EBITDA for the periods presented:

		Three Months Ended												Nine Months Ended
		September 30, 2022				June 30, 2022				September 30, 2021				September 30, 2022				September 30, 2021
Net loss and comprehensive loss		$	(9,196	)		$	(14,796	)		$	(49,761	)		$	(41,477	)		$	(50,263	)
Other expense (income), net*			(26	)			44				213				(64	)			251
Provision for income taxes			1				9				50				23				50
Depreciation and amortization			326				328				239				1,005				713
Equity-based compensation			6,837				8,043				45,731				23,781				45,804
Adjusted EBITDA		$	(2,058	)		$	(6,372	)		$	(3,528	)		$	(16,732	)		$	(3,445	)

* Includes interest (income) expense, foreign currency (gains) losses, and (gains) losses on disposal of fixed assets.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005278/en/

Media

Annie Samuelson

Edelman

713-299-4115

Annie.Samuelson@edelman.com



Investors

Reed Anderson

ICR

646-277-1260

Reed.Anderson@icrinc.com

Source: Zevia PBC

FAQ

What were Zevia's Q3 2022 net sales figures?

Zevia's net sales for Q3 2022 were $44.2 million, up 13.6% year over year.

How did Zevia's gross profit margin change in Q3 2022?

Zevia's gross profit margin improved to 43.3%, a 90 basis point increase sequentially.

What is Zevia's updated sales outlook for 2022?

Zevia expects net sales to be between $158 million to $160 million for 2022, representing a 14.2% to 15.7% increase from 2021.

What was Zevia's adjusted EBITDA loss for Q3 2022?

Zevia reported an adjusted EBITDA loss of $2.1 million for Q3 2022, a significant improvement from the previous year.

What factors affected Zevia's sales performance in Q3 2022?

Zevia cited pressures from inventory management at select customers, which they expect to be temporary.